Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
1999-11-01
2003-11-04
Mertz, Prema (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387900, C530S389100, C530S389200
Reexamination Certificate
active
06642362
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to peptides and proteins isolated during early liver development, genes coding for these peptides and proteins, and antibodies raised to these proteins, and to methods for their use in diagnosing and treating liver disease and other disorders.
BACKGROUND OF THE INVENTION
In the United States and other countries, end stage liver disease due to infection, genetic defects or alcoholic consumption is a major cause of widespread morbidity and mortality, causing great potential hardship and economic loss to millions of people throughout the world. In addition, numerous other diseases, including biliary problems and blood disorders, are associated with disruptions in the many functions carried out by the liver, including iron transport, hepatocyte formation and hematopoiesis. In general, severe problems associated with a breakdown of liver function are practically untreatable, and require a liver transplant as the only cure. However, in light of the great disparity between the number of patients needing liver transplants and the number of donors, thousands upon thousands of people are denied this operation, and transplantation is at the present time not a practical approach to the problem.
At the same time, the precise nature of liver development and the role of early developing liver proteins has not been well understood. To date, no growth factors specific to the liver have been identified or isolated, and the precise molecular mechanisms behind hepatocyte (liver cell) formation remain to be elucidated. There thus has been a long felt need to identify and understand the changes in gene regulation and expression in the developing liver, including the determination as to which genes are switched on and off as a hepatocyte forms and a liver develops. Accordingly, isolating and identifying the genes and proteins which play critical roles in early liver development would be beneficial in understanding the effect of gene regulation and expression in the differentiating liver, and in diagnosing and treating many diseases states involving the liver and liver functions.
SUMMARY OF THE INVENTION
Accordingly, it is thus an object of the present invention to provide genes comprising the nucleic acid sequences encoding early liver developmental proteins, including the liver proteins known as elf 1-3, liyor-1 (145), pk, protein 106, and praja-1.
It is further an object to provide isolated and purified early developing liver proteins encoding by the above genes.
It is still further an object to provide proteins which are characteristic of early liver development and peptides from said proteins and peptides, and to raise antibodies from said proteins and peptides which will be useful as markers, and will be useful in methods of identifying such peptides and proteins, tracing hepatocyte lineage, and treating liver disease.
It is still further an object to use the early developing liver proteins of the present invention to provide liver-specific growth factors for application in diagnosis and treatment of liver disorders.
It is still further an object to provide methods of diagnosing and treating end stage liver disease using the early developing liver proteins of the present invention.
It is even further an object to provide methods of diagnosing and treating other liver disorders and other diseases, including carcinoma, degenerative neurological disorders, anemia, and ataxia, using the early developing liver proteins of the present invention.
These and other objects are achieved by virtue of the present invention which provides genes coding for various proteins which are involved in the differentiation of the developing fetal liver, including the proteins known as elf 1-3, liyor-1 (145), pk, protein 106, praja-1, and a number of other stage-specific genes coding for early-developing liver proteins, and methods for their use in diagnosis and treatment of a variety of liver diseases and other disorders.
REFERENCES:
Devarajan et al., “Identification of a Small Cytoplasmic Ankyrin . . . ”, Journal of Cell Biology, vol. 133, No. 4, May 1996, pp. 819-830.
Chang et al., “Cloning of a Portion of the Chromosomal Gene and cDNA for Human . . . ”, Genomics 17, 1993, pp. 287-293.
Zagon et al., “Localization of Spectrin in Mammalian Brain”, The Journal of Neuroscience, vol. 4, No. 12, Dec. 1984, pp. 3089-3100.
Ryan et al., “Repression of Pax-2 by WT1 during normal kidney development”, The Company of Biologists Limited, 1995, pp. 867-874.
Dubreuil et al., “A &bgr;-Spectrin Isoform from Drosophila (&bgr;H) Is Similar in Size to . . . ”, The Journal of Cell Biology, vol. 111, Nov. 1990, pp. 1849-1858.
Kotula et al. “The Exon-Introl Organization of the Human Erythrocyte &agr;-Spectrin Gene”, Genomics 9, 1991, pp. 131-140.
Wang et al., “The association of the C-terminal region of &bgr;I&Sgr;II spectrin to . . . ”, Biochemical and Biophysical Research Comm., vol. 217, No. 2, Dec. 14, 1995, pp. 608-615.
Lombardo et al., “&bgr;II-Spectrin (Fodin) and &bgr;I&Sgr;2-Spectrin (Muscle) . . . ”, The Journal of Biological Chemistry, vol. 269, No. 46, Nov. 18, 1984, pp. 29212-29219.
Davis et al., “Identification of Two Regions of &bgr;GSpectrin That Bind to Distinct . . . ”, The Journal of Biological Chemistry, vol. 269, No. 6, Feb. 11, 1994, pp. 4409-4416.
Nelson et al., “Localization of phospholipase C-&ggr; 1 to mouse Chromosome 2”, Mammalian Genome 3, 1992, pp. 597-600.
Mayer et al., “A novel viral-oncogene with structural similarity to phospholispase C”, Nature, vol. 332, Mar. 17, 1988, pp. 272-275.
Saraste et al., “Pleckstrin homology domains: a fact file”, Current Opinion in Structural Biology 1995, 5, pp. 403-408.
Rhee et al., “Studies of Inositol Phospholipid-Specific Phospholipase C”, Science, vol. 244, May 4, 1989, pp. 546-550.
Prescott, “A Thematic Series on Phospholipases”, The Journal of Biological Chemistry, vol. 272, No. 24, Jun. 13, 1997, pp. 15043-15047.
Bennett et al., “Molecular cloning and complete amino-acid sequence of form-I . . . ”, Nature, vol. 334, Jul. 21, 1988, pp. 268-272.
Rhee et al., “Regulation of Inositol Phospholipid-specific Phospholipase C Isozymes”, The Journal of Biological Chemistry, vol. 267, No. 18, Jun. 25, 1992, pp. 12393-12396.
Lee et al., “Promoter Region of the Rat Phospholipase C-&ggr;1 Gene”, Biochemical and Biophysical Research Comm., vol. 194, No. 1, Jul. 15, 1993, pp. 294-300.
Touhara et al., “Binding of G Protein &bgr;&ggr;-Subunits to Pleckstrin Homology Domains”, The American Society for Biochemistry and Molecular Biology, pp. 10217-10220.
Jean et al., “Comparative Assignments of the Genes of the Inter-&agr;-inhibitor Family”, Genomics 41, 1997, pp. 139-140.
Salier et al., “Review Article: The inter-&agr;-inhibitor family: from structure to regulation”, Biochem. J. (1996), 315, pp. 1-9.
Chan et al., “The three heavy-chain precursors for the inter-&agr;-inhibitor family in mouse . . . ”, Biochem. J. (1995) 306, pp. 505-512.
Castillo et al., “Subunit structure of bovine ESF . . . ” Federation of European Biochemical Societies, vol. 318, No. 3, Mar. 1993, pp. 292-296.
Zhao et al., “Evidence for the Covalent Binding of SHAP, Heavy Chains of . . . ”, The Journal of Biological Chemistry, vol. 270, No. 44, Nov. 3, 1995, pp. 26657-26663.
Chen et al., “Proteins of the Inter-&agr;-trypsin Inhibitor Family Stabilize . . . ”, The Journal of Biological Chemistry, vol. 269, No. 45, Nov. 11, 1994, pp. 28282-28287.
Saguchi et al., “Isolation and Characterization of the Human Inter-&agr;-Trypsin Inhibitor . . . ”, J. Biochem 119, 898-905 (1996).
Saguchi et al., “Cloning and Characterization of cDNA for Inter-&agr;-Trypsin Inhibitor . . . ”, J. Biochem 117, 1995, No. 14-18.
Salier et al., “Developmentally regulated transcription of the four liver-specific genes . . . ”, Chem. J. (1993) 296, pp. 85-91.
Bhalerao et al., “Molecular Cloning, Characterization and Genetic Mapping . . . ”, The Journal of Biological Chemistry, vol. 270, No. 27, Jul. 7, 1995, pp. 16385-16394.
Salier et al., “Homologous Chromosomal Locations of the Four Genes for . . .
Larson & Taylor PLC
Mertz Prema
LandOfFree
Genes coding proteins for early liver development and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genes coding proteins for early liver development and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genes coding proteins for early liver development and their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3139679